RISK OF BLEEDING IN HEPATOCELLULAR CARCINOMA PATIENTS TREATED WITH ATEZOLIZUMAB/BEVACIZUMAB: A SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
|
作者：
Kim, Young Seok [1 ]
机构：
[1] Soon Chun Hyang Univ, Asan, South Korea
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1794
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Efficacy of Regorafenib in Hepatocellular Carcinoma Patients: A Systematic Review and Meta-Analysis
    Facciorusso, Antonio
    Abd El Aziz, Mohamed A.
    Sacco, Rodolfo
    CANCERS, 2020, 12 (01)
  • [42] Systematic review with meta-analysis: the critical role of dermatological events in patients with hepatocellular carcinoma treated with sorafenib
    Diaz-Gonzalez, Alvaro
    Sanduzzi-Zamparelli, Marco
    Sapena, Victor
    Torres, Ferran
    LLarch, Neus
    Iserte, Gemma
    Forner, Alejandro
    da Fonseca, Leonardo
    Rios, Jose
    Bruix, Jordi
    Reig, Maria
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 49 (05) : 482 - 491
  • [43] Systematic Review with Network Meta-Analysis: Antidiabetic Medication and Risk of Hepatocellular Carcinoma
    Zhou, Yao-Yao
    Zhu, Gui-Qi
    Liu, Tian
    Zheng, Ji-Na
    Cheng, Zhang
    Zou, Tian-Tian
    Braddock, Martin
    Fu, Shen-Wen
    Zheng, Ming-Hua
    SCIENTIFIC REPORTS, 2016, 6
  • [44] Systematic Review with Network Meta-Analysis: Antidiabetic Medication and Risk of Hepatocellular Carcinoma
    Yao-Yao Zhou
    Gui-Qi Zhu
    Tian Liu
    Ji-Na Zheng
    Zhang Cheng
    Tian-Tian Zou
    Martin Braddock
    Shen-Wen Fu
    Ming-Hua Zheng
    Scientific Reports, 6
  • [45] BARIATRIC SURGERY REDUCES THE RISK OF HEPATOCELLULAR CARCINOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Ramai, Daryl
    Singh, Jameel
    Tartaglia, Nicola
    Ambrosi, Antonio
    Khan, Shahab R.
    Chandan, Saurabh
    Bandaru, Praneeth K.
    Ofosu, Andrew
    Facciorusso, Antonio
    GASTROENTEROLOGY, 2021, 160 (06) : S484 - S484
  • [46] Statin Use and Hepatocellular Carcinoma Risk: A Comprehensive Meta-Analysis and Systematic Review
    Rafsanjani, Seyed Mahmood Reza Hashemi
    Rahimi, Rasoul
    Heidari-Soureshjani, Saeid
    Darvishi, Mohammad
    Adeli, Omid-Ali
    Abbaszadeh, Saber
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2024,
  • [47] Bleeding risk with bevacizumab - meta-analysis findings
    Reactions Weekly, 2011, 1345 (1) : 4 - 4
  • [48] Efficacy and Safety of Sorafenib or Lenvatinib for Advanced Hepatocellular Carcinoma after Failure of First-Line Atezolizumab Plus Bevacizumab: A Systematic Review and Meta-Analysis
    Peng, Tzu-Rong
    Weng, Yi-Fang
    Wu, Ta-Wei
    Wu, Chao-Chuan
    Chou, Yi-Chun
    Hsu, Ching-Sheng
    CANCERS, 2024, 16 (16)
  • [49] Alterations of Nutrient Elements in Hepatocellular Carcinoma Patients Treated with Atezolizumab-Bevacizumab
    Xiao, Shuyue
    Huang, Xiaohui
    Liu, Shuer
    Jin, Di
    Liu, Zheng
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2025, 77 (02): : 244 - 251
  • [50] Comparative Efficacy of Atezolizumab plus Bevacizumab and Other Treatment Options for Patients with Unresectable Hepatocellular Carcinoma: A Network Meta-Analysis
    Vogel, Arndt
    Rimassa, Lorenza
    Sun, Hui-Chan
    Abou-Alfa, Ghassan K.
    El-Khoueiry, Anthony
    Pinato, David J.
    Sanchez Alvarez, Javier
    Daigl, Monica
    Orfanos, Panos
    Leibfried, Michael
    Blanchet Zumofen, Marie-Helene
    Gaillard, Vincent E.
    Merle, Philippe
    LIVER CANCER, 2021, 10 (03) : 240 - 248
12345